Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:14 pm Sale | 2025-09-30 | 13G | Dyne Therapeutics, Inc. DYN | RA Capital Management, L.P. | 0 0.000% | -9,714,392 (Position Closed) | Filing History |
| 2025-11-14 4:13 pm Purchase | 2025-09-30 | 13G | Dianthus Therapeutics, Inc. DNTH | RA Capital Management, L.P. | 3,866,733 9.500% | 1,000,000 (+34.88%) | Filing History |
| 2025-11-14 4:13 pm Purchase | 2025-09-30 | 13G | Avidity Biosciences, Inc. RNA | RA Capital Management, L.P. | 8,641,031 5.900% | 2,340,623 (+37.15%) | Filing History |
| 2025-11-14 4:12 pm Purchase | 2025-09-30 | 13G | Avalo Therapeutics, Inc. AVTX | RA Capital Management, L.P. | 1,386,167 9.900% | 291,760 (+26.66%) | Filing History |
| 2025-11-13 8:47 pm Purchase | 2025-11-11 | 13D | Wave Life Sciences Ltd. WVE | RA Capital Management, L.P. | 25,453,010 14.600% | 38,845 (+0.15%) | Filing History |
| 2025-11-12 8:27 pm Purchase | 2025-11-04 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | RA Capital Management, L.P. | 15,302,186 7.300% | 15,302,186 (New Position) | Filing History |
| 2025-11-10 4:40 pm Purchase | 2025-11-06 | 13D | Cidara Therapeutics, Inc. CDTX | RA Capital Management, L.P. | 3,372,923 10.700% | 7,400 (+0.22%) | Filing History |
| 2025-11-07 4:59 pm Sale | 2025-11-05 | 13D | Sionna Therapeutics, Inc. SION | RA Capital Management, L.P. | 10,071,712 22.600% | -373,610 (-3.58%) | Filing History |
| 2025-11-07 4:47 pm Purchase | 2025-11-05 | 13D | LENZ Therapeutics, Inc. LENZ | RA Capital Management, L.P. | 4,265,106 13.600% | 4,500 (+0.11%) | Filing History |
| 2025-11-06 4:29 pm Sale | 2025-11-04 | 13D | Werewolf Therapeutics, Inc. HOWL | RA Capital Management, L.P. | 6,681,307 13.800% | -65,500 (-0.97%) | Filing History |
| 2025-11-03 4:42 pm Sale | 2025-10-30 | 13D | 89bio, Inc. ETNB | RA Capital Management, L.P. | 0 0.000% | -20,013,733 (Position Closed) | Filing History |
| 2025-10-30 6:42 pm Sale | 2025-10-28 | 13D | Vor Biopharma Inc. VOR | RA Capital Management, L.P. | 810,671 11.500% | -375,829 (-31.68%) | Filing History |
| 2025-10-30 4:36 pm Purchase | 2025-10-23 | 13G | Rani Therapeutics Holdings, Inc. RANI | RA Capital Management, L.P. | 9,882,477 9.900% | 9,882,477 (New Position) | Filing History |
| 2025-10-27 8:06 pm Sale | 2025-10-23 | 13D | Vor Biopharma Inc. VOR | RA Capital Management, L.P. | 1,186,500 17.300% | -246,193 (-17.18%) | Filing History |
| 2025-10-27 4:07 pm Purchase | 2025-10-20 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | RA Capital Management, L.P. | 5,000,000 6.900% | 5,000,000 (New Position) | Filing History |
| 2025-10-24 4:13 pm Purchase | 2025-10-17 | 13G | C4 Therapeutics, Inc. CCCC | RA Capital Management, L.P. | 9,441,256 9.900% | 9,441,256 (New Position) | Filing History |
| 2025-10-20 6:58 pm Sale | 2025-10-16 | 13D | Vor Biopharma Inc. VOR | RA Capital Management, L.P. | 1,432,693 20.900% | -555,964 (-27.96%) | Filing History |
| 2025-10-16 7:35 pm Purchase | 2025-10-08 | 13G | Jade Biosciences, Inc. JBIO | RA Capital Management, L.P. | 3,214,969 7.000% | 1,890,015 (+142.65%) | Filing History |
| 2025-10-09 4:28 pm Purchase | 2025-10-02 | 13G | Palisade Bio, Inc. PALI | RA Capital Management, L.P. | 9,935,761 9.900% | 9,935,761 (New Position) | Filing History |
| 2025-10-03 4:26 pm Purchase | 2025-09-26 | 13D | SAB Biotherapeutics, Inc. SABS | RA Capital Management, L.P. | 4,401,500 9.900% | 4,401,500 (New Position) | Filing History |